VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
Ruikang Pharmaceutical Clarifies No Agreement Signed with AstraZeneca for Evusheld (Tixagevimab/Cilgavimab) Mainland China Distribution Rights
Ruikang Pharmaceutical Clarifies No Agreement Signed with AstraZeneca for Evusheld (Tixagevimab/Cilgavimab) Mainland China Distribution Rights
Jul 07, 2022 18:45 CST Updated 23:31
Share:
AstraZeneca
Biopharmaceutical Manufacturer
Realcan Pharmaceutical Group Co., Ltd.: As of the date of this announcement, the company has not signed any agreement with AstraZeneca regarding the agency of Evusheld in mainland China.